2018
DOI: 10.1101/261628
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Generating genomic platforms to studyCandida albicanspathogenesis

Abstract: The advent of the genomic era has made elucidating gene function at large scale a pressing challenge. ORFeome collections, whereby almost all ORFs of a given species are cloned and can be subsequently leveraged in multiple functional genomic approaches, represent valuable resources towards this endeavor. Here we provide novel, genome-scale tools for the study of Candida albicans, a commensal yeast that is also responsible for frequent superficial and disseminated infections in humans. We have generated an ORFe… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 62 publications
0
4
0
Order By: Relevance
“…The resulting strain was transformed with plasmid CIp10 to generate the prototrophic strain CEC4425 (Table S11) that we used as a BFP‐labelled control for our 1:1 competitive assays (Figure c,d). Strains overexpressing CRZ2 from the constitutive TDH3 promoter were generated by transferring the CRZ2 ORF from the respective pDONR207 derivative to the Gateway‐compatible CIp10‐P TDH3 ‐GTW plasmid (Legrand et al ) followed by transformation of strain BWP17AH (CEC161; Chauvel et al, ) to generate three independent P TDH3 ‐driven CRZ2 ‐overexpression clones (C26, C27, and C28; Table S11). The CEC161 strain was also transformed with CIp10‐P TDH3 ‐GFP, generating strain CEC4267 (Table S11), to serve as a control for phenotypic assays.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The resulting strain was transformed with plasmid CIp10 to generate the prototrophic strain CEC4425 (Table S11) that we used as a BFP‐labelled control for our 1:1 competitive assays (Figure c,d). Strains overexpressing CRZ2 from the constitutive TDH3 promoter were generated by transferring the CRZ2 ORF from the respective pDONR207 derivative to the Gateway‐compatible CIp10‐P TDH3 ‐GTW plasmid (Legrand et al ) followed by transformation of strain BWP17AH (CEC161; Chauvel et al, ) to generate three independent P TDH3 ‐driven CRZ2 ‐overexpression clones (C26, C27, and C28; Table S11). The CEC161 strain was also transformed with CIp10‐P TDH3 ‐GFP, generating strain CEC4267 (Table S11), to serve as a control for phenotypic assays.…”
Section: Methodsmentioning
confidence: 99%
“…To create a TAP epitope‐tagged version of CRZ2 , the CRZ2 ORF was transferred from the corresponding pDONR207 to the Gateway‐compatible CIp10‐P TET ‐TAP‐GTW that allows P TET ‐driven expression of N‐terminally‐tagged ORFs (Legrand et al, , in press). The ura3 auxotrophic derivative of the crz2 Δ/ crz2 Δ mutants was first transformed with plasmid pNIMX then with CIp10‐P TET ‐TAP‐ CRZ2 or CIp10‐P TET ‐ CRZ2 (untagged control) to generate strains C251, C252 (two independent TAP‐tagged clones) and C255, C257, C258 (three independent untagged control clones), respectively (Table S11).…”
Section: Methodsmentioning
confidence: 99%
“…Overexpression screens can also help dissect molecular pathways (53)(54)(55). In C. albicans, several techniques exist for genetic overexpression (39), including promoter replacement strategies (55)(56)(57)(58), the generation of ORFeome collection strains (59,60), and CRISPR-based methods (27). While these these tools have made important contributions to understanding overexpression in C. albicans, there remains a need for simple and rapid methods to efficiently target fungal genes of interest for overexpression, and to do so in diverse strain backgrounds.…”
Section: Introductionmentioning
confidence: 99%
“…These resources have been generated for several model organisms, including humans, Escherichia coli, Caenorhabditis elegans , and Arabidopsis thaliana (1823). ORFeomes have also been developed for the fungal kingdom, including fission yeast (18), budding yeast (24) and, most recently, the human pathogenic yeast Candida albicans (8). Usually, ORFeomes are compatible with the Gateway ® cloning technology (Invitrogen), which enables rapid and high throughput recombinase-based transfer of an ORF coding sequence to generate expression vectors (25, 26).…”
Section: Introductionmentioning
confidence: 99%